Article: Vaccine maker reports net loss of $3.2M in second quarter.

2003 AUG 18 - (NewsRx.com & NewsRx.net) -- Avant Immunotherapeutics, Inc., (AVAN) reported financial results for the second quarter ended June 30, 2003.

The company reported a net loss of $3.2 million, or $.05 per share, for the second quarter of 2003 compared to a net loss of $5.2 million, or $.09 per share, for the second quarter of 2002. The decreased loss for the second quarter of 2003 results primarily from an increase in revenue and a decrease in operating expense compared to the same period in 2002, offset in part by a decrease in investment income.

The increase in revenue of $435,600, or 67.8%, primarily reflects revenue of $818,600 recognized ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!